» Download Public Reports
About 200 reports
- Company report
- October 2012
- 2 pages
... To be the vigilant stewards of cord blood stem cells for canadian families long-term. About insception insception is the largest cord blood program in canada, with over 39,000 cord blood units banked. Insception ...
December 2012
... Clinical researc tria esign assistance Waiver of prescription drug user fees. Type 1 plasminogen deficiency Plasminogen: plasminogen is a naturally occurring protein synthesized by the liver ...
September 2012
... Commercialized will continue to increase. Ii. Once a gm crop is authorized for commercial use in a country, trace amounts of that crop may become mixed with other varieties of the same crop or other crops ...
September 2012
... Engineering as a quicker and more preciose continuation of the practice of breeding and selecting plants with desirable characteristics. In any case, gm crops play an increasingly important role in global ...
February 2013
... On human cancer cell lines that are genetically modified to secrete granulocyte-macrophage colony-stimulating factor (gm-csf), an immune-stimulatory cytokine. We continue to see promise with gvax, Said ...
March 2013
... Including new crop plants, are regulated in the same manner, broadly speaking, as conventionally-derived products. The canadian regulatory framework for biotechnology 9 for example Herbicide tolerance ...
February 2013
... On human cancer cell lines that are genetically modified to secrete granulocyte-macrophage colony-stimulating factor (gm-csf), an immune-stimulatory cytokine. We continue to see promise with gvax, Said ...
» Purchase Premium Reports
(From $ 125 - $ 844)
64 reports
- $ 898
- Industry report
- May 2013
- by Euromonitor International
During 2010, retail sales of sports nutrition products grew 3% to reach C$122 million in current value terms. Sports nutrition registered slower growth than in previous years of the review period, largely ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
April 2013
$ 250
Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...
March 2013
$ 250
Summary University Health Network (UHN) is a research organization. The university discovers stem cells, pioneering deep brain simulator and performing lung transplants. It provides services in the areas ...
March 2013
$ 250
Summary Thallion Pharmaceuticals Inc. (Thallion) is a biotechnology company. It develops new pharmaceutical products in the field of oncology and infectious diseases. Currently, the company is focusing ...
March 2013
$ 250
Summary InNexus Biotechnology Inc. (InNexus) is a development stage biotechnology company focuses on the development of the next generation of monoclonal antibodies using its Dynamic Cross-linking (DXL) ...
March 2013
$ 250
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
